BIOGEN INC (IDP.DE) Stock Fundamental Analysis
FRA:IDP - Deutsche Boerse Ag - US09062X1037 - Common Stock - Currency: EUR
Taking everything into account, IDP scores 5 out of 10 in our fundamental rating. IDP was compared to 71 industry peers in the Biotechnology industry. IDP scores excellent on profitability, but there are some minor concerns on its financial health. IDP has a bad growth rate and is valued cheaply. These ratings would make IDP suitable for value investing!
1. Profitability
1.1 Basic Checks
In the past year IDP was profitable.
IDP had a positive operating cash flow in the past year.
In the past 5 years IDP has always been profitable.
In the past 5 years IDP always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of IDP (5.28%) is better than 83.10% of its industry peers.
The Return On Equity of IDP (8.71%) is better than 81.69% of its industry peers.
The Return On Invested Capital of IDP (9.95%) is better than 87.32% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for IDP is in line with the industry average of 11.84%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.28% | ||
| ROE | 8.71% | ||
| ROIC | 9.95% |
ROA(3y)7.52%
ROA(5y)9.06%
ROE(3y)13.45%
ROE(5y)18.41%
ROIC(3y)10.57%
ROIC(5y)13.65%
1.3 Margins
With an excellent Profit Margin value of 15.07%, IDP belongs to the best of the industry, outperforming 83.10% of the companies in the same industry.
In the last couple of years the Profit Margin of IDP has declined.
Looking at the Operating Margin, with a value of 26.30%, IDP belongs to the top of the industry, outperforming 88.73% of the companies in the same industry.
IDP's Operating Margin has declined in the last couple of years.
IDP has a better Gross Margin (75.58%) than 73.24% of its industry peers.
IDP's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.3% | ||
| PM (TTM) | 15.07% | ||
| GM | 75.58% |
OM growth 3Y-4.87%
OM growth 5Y-12.22%
PM growth 3Y5.99%
PM growth 5Y-16.26%
GM growth 3Y-1.51%
GM growth 5Y-2.23%
2. Health
2.1 Basic Checks
With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), IDP is creating some value.
Compared to 1 year ago, IDP has more shares outstanding
IDP has less shares outstanding than it did 5 years ago.
IDP has a better debt/assets ratio than last year.
2.2 Solvency
IDP has an Altman-Z score of 2.76. This is not the best score and indicates that IDP is in the grey zone with still only limited risk for bankruptcy at the moment.
IDP's Altman-Z score of 2.76 is fine compared to the rest of the industry. IDP outperforms 74.65% of its industry peers.
The Debt to FCF ratio of IDP is 2.74, which is a good value as it means it would take IDP, 2.74 years of fcf income to pay off all of its debts.
IDP's Debt to FCF ratio of 2.74 is amongst the best of the industry. IDP outperforms 87.32% of its industry peers.
A Debt/Equity ratio of 0.27 indicates that IDP is not too dependend on debt financing.
IDP has a Debt to Equity ratio of 0.27. This is comparable to the rest of the industry: IDP outperforms 56.34% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 2.74 | ||
| Altman-Z | 2.76 |
ROIC/WACC1.1
WACC9.01%
2.3 Liquidity
A Current Ratio of 1.44 indicates that IDP should not have too much problems paying its short term obligations.
IDP has a worse Current ratio (1.44) than 60.56% of its industry peers.
IDP has a Quick Ratio of 1.01. This is a normal value and indicates that IDP is financially healthy and should not expect problems in meeting its short term obligations.
IDP's Quick ratio of 1.01 is on the low side compared to the rest of the industry. IDP is outperformed by 67.61% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.01 |
3. Growth
3.1 Past
IDP shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 3.06%.
Measured over the past years, IDP shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -13.31% on average per year.
The Revenue has been growing slightly by 1.59% in the past year.
Measured over the past years, IDP shows a decrease in Revenue. The Revenue has been decreasing by -7.62% on average per year.
EPS 1Y (TTM)3.06%
EPS 3Y-4.95%
EPS 5Y-13.31%
EPS Q2Q%-17.71%
Revenue 1Y (TTM)1.59%
Revenue growth 3Y-4.13%
Revenue growth 5Y-7.62%
Sales Q2Q%6.13%
3.2 Future
Based on estimates for the next years, IDP will show a small growth in Earnings Per Share. The EPS will grow by 1.94% on average per year.
The Revenue is expected to decrease by -0.29% on average over the next years.
EPS Next Y-7.16%
EPS Next 2Y-2.11%
EPS Next 3Y0.35%
EPS Next 5Y1.94%
Revenue Next Year-3.85%
Revenue Next 2Y-2.85%
Revenue Next 3Y-1.54%
Revenue Next 5Y-0.29%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
IDP is valuated reasonably with a Price/Earnings ratio of 8.24.
IDP's Price/Earnings ratio is rather cheap when compared to the industry. IDP is cheaper than 94.37% of the companies in the same industry.
When comparing the Price/Earnings ratio of IDP to the average of the S&P500 Index (26.25), we can say IDP is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 8.26, the valuation of IDP can be described as reasonable.
97.18% of the companies in the same industry are more expensive than IDP, based on the Price/Forward Earnings ratio.
IDP is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.15, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.24 | ||
| Fwd PE | 8.26 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, IDP is valued cheaply inside the industry as 91.55% of the companies are valued more expensively.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of IDP indicates a rather cheap valuation: IDP is cheaper than 92.96% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 8.32 | ||
| EV/EBITDA | 6.93 |
4.3 Compensation for Growth
The decent profitability rating of IDP may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-2.11%
EPS Next 3Y0.35%
5. Dividend
5.1 Amount
No dividends for IDP!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
FRA:IDP (5/30/2025, 7:00:00 PM)
115
-0.25 (-0.22%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)
Earnings (Next)
Inst Owners94.24%
Inst Owner ChangeN/A
Ins Owners0.12%
Ins Owner ChangeN/A
Market Cap16.85B
Analysts72.56
Price Target155.05 (34.83%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)8.97%
Min EPS beat(2)0.67%
Max EPS beat(2)17.28%
EPS beat(4)4
Avg EPS beat(4)13.01%
Min EPS beat(4)0.67%
Max EPS beat(4)28.61%
EPS beat(8)8
Avg EPS beat(8)8.78%
EPS beat(12)12
Avg EPS beat(12)10.47%
EPS beat(16)14
Avg EPS beat(16)9.94%
Revenue beat(2)2
Avg Revenue beat(2)3.39%
Min Revenue beat(2)0.11%
Max Revenue beat(2)6.67%
Revenue beat(4)3
Avg Revenue beat(4)1.89%
Min Revenue beat(4)-0.68%
Max Revenue beat(4)6.67%
Revenue beat(8)5
Avg Revenue beat(8)0.61%
Revenue beat(12)8
Avg Revenue beat(12)1.03%
Revenue beat(16)11
Avg Revenue beat(16)1.28%
PT rev (1m)-7.77%
PT rev (3m)-30.15%
EPS NQ rev (1m)-0.52%
EPS NQ rev (3m)-0.47%
EPS NY rev (1m)-4.93%
EPS NY rev (3m)-5.41%
Revenue NQ rev (1m)-0.21%
Revenue NQ rev (3m)-0.46%
Revenue NY rev (1m)0.48%
Revenue NY rev (3m)0.65%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.24 | ||
| Fwd PE | 8.26 | ||
| P/S | 1.95 | ||
| P/FCF | 8.32 | ||
| P/OCF | 7.4 | ||
| P/B | 1.13 | ||
| P/tB | 20.84 | ||
| EV/EBITDA | 6.93 |
EPS(TTM)13.95
EY12.13%
EPS(NY)13.92
Fwd EY12.1%
FCF(TTM)13.82
FCFY12.01%
OCF(TTM)15.54
OCFY13.51%
SpS59.08
BVpS102.19
TBVpS5.52
PEG (NY)N/A
PEG (5Y)N/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.28% | ||
| ROE | 8.71% | ||
| ROCE | 11.36% | ||
| ROIC | 9.95% | ||
| ROICexc | 11.23% | ||
| ROICexgc | 55.5% | ||
| OM | 26.3% | ||
| PM (TTM) | 15.07% | ||
| GM | 75.58% | ||
| FCFM | 23.39% |
ROA(3y)7.52%
ROA(5y)9.06%
ROE(3y)13.45%
ROE(5y)18.41%
ROIC(3y)10.57%
ROIC(5y)13.65%
ROICexc(3y)12.43%
ROICexc(5y)16.11%
ROICexgc(3y)38.35%
ROICexgc(5y)40.12%
ROCE(3y)12.07%
ROCE(5y)15.58%
ROICexcg growth 3Y14.15%
ROICexcg growth 5Y-5.35%
ROICexc growth 3Y-15.93%
ROICexc growth 5Y-20.8%
OM growth 3Y-4.87%
OM growth 5Y-12.22%
PM growth 3Y5.99%
PM growth 5Y-16.26%
GM growth 3Y-1.51%
GM growth 5Y-2.23%
F-Score6
Asset Turnover0.35
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.27 | ||
| Debt/FCF | 2.74 | ||
| Debt/EBITDA | 1.38 | ||
| Cap/Depr | 40.34% | ||
| Cap/Sales | 2.91% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 78.44% | ||
| Profit Quality | 155.18% | ||
| Current Ratio | 1.44 | ||
| Quick Ratio | 1.01 | ||
| Altman-Z | 2.76 |
F-Score6
WACC9.01%
ROIC/WACC1.1
Cap/Depr(3y)54.43%
Cap/Depr(5y)68.89%
Cap/Sales(3y)3.09%
Cap/Sales(5y)3.21%
Profit Quality(3y)99.34%
Profit Quality(5y)120.98%
High Growth Momentum
Growth
EPS 1Y (TTM)3.06%
EPS 3Y-4.95%
EPS 5Y-13.31%
EPS Q2Q%-17.71%
EPS Next Y-7.16%
EPS Next 2Y-2.11%
EPS Next 3Y0.35%
EPS Next 5Y1.94%
Revenue 1Y (TTM)1.59%
Revenue growth 3Y-4.13%
Revenue growth 5Y-7.62%
Sales Q2Q%6.13%
Revenue Next Year-3.85%
Revenue Next 2Y-2.85%
Revenue Next 3Y-1.54%
Revenue Next 5Y-0.29%
EBIT growth 1Y21.69%
EBIT growth 3Y-8.8%
EBIT growth 5Y-18.9%
EBIT Next Year9.62%
EBIT Next 3Y4.45%
EBIT Next 5Y5.69%
FCF growth 1Y61.56%
FCF growth 3Y-9.06%
FCF growth 5Y-17.06%
OCF growth 1Y53.87%
OCF growth 3Y-7.56%
OCF growth 5Y-16.49%